Clinical Pharmacy Services, Pharmacist Staffing, and Drug Costs in United States Hospitals
- 1 December 1999
- journal article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 19 (12) , 1354-1362
- https://doi.org/10.1592/phco.19.18.1354.30893
Abstract
We evaluated direct relationships and associations among clinical pharmacy services, pharmacist staffing, and drug costs in United States hospitals. A database was constructed from the 1992 American Hospital Association's Abridged Guide to the Health Care Field and the 1992 National Clinical Pharmacy Services database. Multiple regression analysis, controlling for severity of illness, was employed to determine the associations. The study population consisted of 934 hospitals. Four clinical pharmacy services were associated with lower drug costs: in-service education, $77,879.19+/-$56,203.42 (a total of $48,518,735.37 for the 623 hospitals offering this service, p=0.016); drug information, $430,579.84+/-$299,232.76 ($90,852,346.24 for the 211 hospitals offering this service, p=0.015); drug protocol management, $137,333.67+/-$98,617.83 ($45,045,443.76 for the 328 hospitals offering this service, p=0.049); and admission drug histories, $213,388.21+/-$201,537.85 ($5,548,093.46 for the 26 hospitals offering this service, p=0.011). As staffing increased for hospital pharmacy administrators (p<0.0001), dispensing pharmacists (p<0.0001), and pharmacy technicians (p<0.0001), drug costs increased. As staffing increased for clinical pharmacists, drug costs decreased (p=0.018). The results of this study show that increased staff levels of clinical pharmacists and some clinical pharmacy services are associated with reduced hospital drug costs.Keywords
This publication has 29 references indexed in Scilit:
- Drug-related morbidity and mortality. A cost-of-illness modelArchives of internal medicine (1960), 1995
- Systems analysis of adverse drug events. ADE Prevention Study GroupPublished by American Medical Association (AMA) ,1995
- Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study GroupJAMA, 1995
- Hospital characteristics and quality of carePublished by American Medical Association (AMA) ,1992
- The relationship of house staff experience to the cost and quality of inpatient carePublished by American Medical Association (AMA) ,1990
- Hospital Characteristics and Mortality RatesNew England Journal of Medicine, 1989
- The Effects of Regulation, Competition, and Ownership on Mortality Rates among Hospital InpatientsNew England Journal of Medicine, 1988
- Sustained improvement in drug documentation, compliance, and disease control. A four-year analysis of an ambulatory care modelArchives of internal medicine (1960), 1984
- Case Mix, Costs, and OutcomesNew England Journal of Medicine, 1984
- Improving Drug-Therapy Decisions through Educational OutreachNew England Journal of Medicine, 1983